UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 15, 2025

GENTEX CORPORATION

(Exact name of registrant as specified in its charter)


Michigan	0-10235	38-2030505
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

600 North Centennial Street
Zeeland
Michigan		49464
(Address of principal executive offices)		(Zip Code)

Registrant's telephone number, including area code: (616) 772-1800

_____________________________________________________________

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.06 per share	GNTX	NASDAQ Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Section 5 – Corporate Governance and Management

Item 5.07 Submission of Matters to a Vote of Security Holders.

On May 15, 2025, the Company held its 2025 Annual Meeting of the Shareholders. The matters listed and described briefly below were submitted to a vote of the shareholders through the solicitation of proxies. The proposals are described in detail in the Company's Proxy Statement filed on April 3, 2025. The voting results are as follows:

Election of Directors

The following individuals were elected to serve as directors of the Company to hold office for a one (1) year term expiring in 2026:


Nominee	Votes For	Votes Withheld	Broker Non-Votes
Mr. Joseph Anderson	179,607,747	6,257,774	16,942,717
Ms. Leslie Brown	172,233,279	13,632,242	16,942,717
Mr. Garth Deur	184,935,604	929,917	16,942,717
Mr. Steve Downing	185,222,131	643,390	16,942,717
Dr. Bill Pink	185,120,325	745,196	16,942,717
Mr. Richard Schaum	173,411,505	12,454,016	16,942,717
Ms. Kathleen Starkoff	185,250,492	615,029	16,942,717
Mr. Brian Walker	184,616,246	1,249,275	16,942,717
Dr. Ling Zang	179,669,252	6,196,269	16,942,717

Proposal to Ratify the Appointment of Ernst & Young LLP as the Company's Auditors for the Fiscal Year Ended December 31, 2025

The shareholders did ratify the appointment of Ernst & Young LLP to serve as the Company's auditors for the fiscal year ending December 31, 2025:


Votes For	Votes Against	Abstentions	Broker Non-Votes
197,708,727	4,965,245	134,266

Proposal to Approve, on an Advisory Basis, the Compensation of the Company's Named Executive Officers

The shareholders did approve, on an advisory basis, the compensation of the Company's named executive officers:


Votes For	Votes Against	Abstentions	Broker Non-Votes
177,542,868	8,059,787	262,866	16,942,717

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Dated: May 19, 2025 GENTEX CORPORATION

(Registrant)

By /s/ Kevin Nash

Kevin Nash

Chief Financial Officer and

Vice President - Finance

GENTEX CORP 8-K